RESUMO
OBJECTIVES: Renal dysfunction is a significant cause of morbidity and mortality among HIV-positive individuals. This study evaluated renal dysfunction in a cohort of adults who started antiretroviral treatment (ART) regardless of CD4 count at three Department of Health (DOH) clinics included in the HIV Prevention Trials Network 071 (HPTN 071) Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART) trial. METHODS: A retrospective cohort analysis of routine data for HIV-positive individuals starting ART between January 2014 and November 2015 was completed. Incident renal dysfunction was defined as an estimated glomerular filtration rate (eEGFR) < 60 mL/min after ART initiation among individuals with a baseline (pre-ART) eGFR ≥ 60 mL/min. RESULTS: Overall, 2423 individuals, with a median baseline CD4 count of 328 cells/µL [interquartile range (IQR) 195-468 cells/µL], were included in the analysis. Forty-seven individuals had a baseline eGFR < 60 mL/min. Among 1634 nonpregnant individuals started on a tenofovir-containing ART regimen and with a baseline eGFR ≥ 60 mL/min, 27 developed an eGFR < 60 mL/min on ART. Regression analysis showed lower odds of baseline eGFR < 60 mL/min at baseline CD4 counts of > 500 cells/µL [adjusted odds ratio (aOR) 0.29; 95% confidence interval (CI) 0.11-0.80], 351-500 cells/µL (aOR 0.22; 95% CI 0.08-0.59) and 201-350 (aOR 0.48; 95% CI: 0.24-0.97) compared with baseline CD4 counts < 200 cells/µL. CONCLUSIONS: This study showed low rates of renal dysfunction at baseline and on ART, with lower rates of baseline renal dysfunction among individuals with baseline CD4 counts > 200 cells/µL. Strategies that use baseline characteristics, such as age, to identify individuals at high risk of renal dysfunction on ART for enhanced eGFR monitoring may be effective and should be the subject of future research.
Assuntos
Antirretrovirais/uso terapêutico , Infecções por HIV/complicações , Infecções por HIV/tratamento farmacológico , Nefropatias/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Contagem de Linfócito CD4 , Feminino , Taxa de Filtração Glomerular , Infecções por HIV/patologia , Infecções por HIV/prevenção & controle , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , África do Sul , Inquéritos e Questionários , Adulto JovemRESUMO
BACKGROUND: There are limited data comparing interferon-gamma release assays (IGRAs) for the detection of Mycobacterium tuberculosis infection in highly endemic settings. METHODS: A cross-sectional household contact study was conducted to measure the agreement of two IGRAs in relation to the tuberculin skin test (TST) to detect M tuberculosis infection and to assess the influence of M tuberculosis exposure and age. RESULTS: In 82 individuals in household contact, 93% of children and 42% of adults had a high M tuberculosis contact score. The TST was positive in 78% of adults and 54% of children, the T-SPOT.TB was positive in 89% of children and 66% of adults and the QuantiFERON TB Gold (QTF) was positive in a similar proportion of adults and children (38.1% and 39.6%). In children there was poor agreement between the TST and T-SPOT.TB (kappa = -0.15) and the T-SPOT.TB and the QTF (kappa = -0.03), but good agreement between the TST and the QTF (kappa = 0.78) using 10 mm cut-off. In adults there was fair to moderate agreement between the TST and T-SPOT.TB (kappa = 0.38), the TST and QTF (kappa = 0.34) and T-SPOT.TB and QTF (kappa = -0.50). High levels of exposure to M tuberculosis were associated with at least a sevenfold odds of being T-SPOT.TB positive (95% CI 7.67 to 508.69) and a threefold odds of being QTF positive (95% CI 3.02 to 30.54). There was a significant difference in the magnitude of T-SPOT.TB early secretory antigenic target (ESAT)-6 and culture filtrate protein 10 kD (CFP-10) spot counts between adults and children. CONCLUSIONS: The T-SPOT.TB may be more sensitive than the TST or QTF for detecting recent M tuberculosis infection in children. Differences between assays and the predictive utility of these findings for subsequent disease development should be prospectively assessed.
Assuntos
Interferon gama/metabolismo , Linfócitos T/imunologia , Tuberculose Pulmonar/imunologia , Adolescente , Adulto , Idoso , Antígenos de Bactérias/metabolismo , Vacina BCG/imunologia , Proteínas de Bactérias/metabolismo , Pré-Escolar , Estudos Transversais , Humanos , Imunidade Celular , Lactente , Pessoa de Meia-Idade , Mycobacterium tuberculosis/imunologia , Teste Tuberculínico/métodos , Tuberculose Pulmonar/diagnóstico , Adulto JovemRESUMO
Biomarkers for treatment response would facilitate the testing of urgently needed new anti-tuberculous drugs. The present study investigated the profiles of 30 proinflammatory, anti-inflammatory and angiogenic factors [epidermal growth factor, eotaxin, fractalkine, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, interleukin (IL)-1alpha, IL-1beta, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p40, IL-12p70, IL-13, IL-15, IL-17, interferon-gamma, interferon-inducible protein-10, Krebs von den Lungen-6, monocyte chemotactic protein-1, macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, sCD40L, transforming growth factor-alpha, tumour necrosis factor-alpha and vascular endothelial growth factor] in the plasma of 12 healthy tuberculin skin test-positive community controls and 20 human immunodeficiency virus-negative patients with active tuberculosis (TB) and identified potential biomarkers for early treatment response. We showed differences in the level of circulating cytokines between healthy controls and TB patients, but also between fast responders and slow responders to anti-tuberculosis treatment. The general discriminant analysis based on pre-treatment and week 1 measurements identified 10 sets of three-variable models that could classify fast and slow responders with up to 83% accuracy. Overall, this study shows the potential of cytokines as indicators of anti-tuberculosis treatment response.
Assuntos
Antituberculosos/uso terapêutico , Citocinas/sangue , Tuberculose Pulmonar/tratamento farmacológico , Adolescente , Adulto , Biomarcadores/sangue , Monitoramento de Medicamentos/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Resultado do Tratamento , Teste Tuberculínico , Tuberculose Pulmonar/imunologia , Adulto JovemRESUMO
OBJECTIVE: To determine the population-based incidence of disseminated bacille Calmette-Guérin (BCG) disease in HIV-infected infants (aged Assuntos
Soropositividade para HIV
, Tuberculose Bovina/epidemiologia
, Animais
, Vacina BCG/efeitos adversos
, Bovinos
, Comorbidade
, Humanos
, Lactente
, Transmissão Vertical de Doenças Infecciosas
, Mycobacterium bovis
, Vigilância da População
, Estudos Prospectivos
, África do Sul/epidemiologia
, Tuberculose Bovina/transmissão
RESUMO
BACKGROUND: Global control of the tuberculosis (TB) epidemic remains poor, especially in high-burden settings where ongoing transmission sustains the epidemic. In such settings, a significant amount of transmission takes place outside the household, and practical approaches to understanding transmission at community level are needed. OBJECTIVE: To identify and map potential TB transmission 'hot spots' across high-burden communities. SETTING AND DESIGN: Our method draws on data that qualitatively describe a high-burden community in Cape Town, South Africa. Established transmission principles are applied to grade the potential TB transmission risk posed by congregate settings in the community. Geographic information systems (GIS) technology then creates a visual map, locating potential transmission 'hot spots' in the community. RESULTS: Drinking places (shebeens), clinics and churches (often gatherings in confined homes) emerge as gathering places that potentially pose a high transmission risk, particularly if located in overcrowded and impoverished areas of the community. CONCLUSION: This proof-of-concept study demonstrates that combining qualitative techniques with GIS mapping may improve our understanding of potential TB transmission within a community and guide public health interventions to enhance TB control efforts.
Assuntos
Controle de Doenças Transmissíveis/métodos , Tuberculose/transmissão , Efeitos Psicossociais da Doença , Países em Desenvolvimento , Sistemas de Informação Geográfica , Humanos , Comunicação Interdisciplinar , Vigilância da População , Pesquisa Qualitativa , África do SulRESUMO
SETTING: Western Cape Province, South Africa. OBJECTIVES: To describe the prevalence of tuberculosis (TB) infection and disease in children with type 1 diabetes and to investigate the association between glycaemic control and prevalence of TB infection and disease. DESIGN: Cross-sectional hospital-based study conducted at two public referral hospitals. All children and adolescents (aged <21 years) with type 1 diabetes underwent a Mantoux tuberculin skin test (>or=10 mm classified as Mycobacterium tuberculosis infection), measurement of glycosylated haemoglobin and a chest radiograph. Patients with symptoms suggestive of TB were investigated using mycobacterial culture. Radiologically and/or bacteriologically confirmed disease was classified as TB disease. RESULTS: Of 291 eligible patients, 258 (88.7%) were included (58% female). The prevalence of M. tuberculosis infection was 29.8% (95%CI 24.2-35.4); nine patients were diagnosed with prevalent TB disease (point prevalence disease 3488 per 100,000 population). Poor glycaemic control (hazard ratio 1.39, 95%CI 1.18-1.63 per unit increase in glycated haemoglobin [HbA1c]) and contact with a TB source case (P = 0.0011) was associated with prevalent TB disease. CONCLUSIONS: There is a high prevalence of TB disease in diabetic children and adolescents in this setting. Routine TB screening of children with type 1 diabetes may be indicated in settings highly endemic for TB. Preventive treatment should be considered for diabetic children with proof of TB exposure and/or infection.
Assuntos
Diabetes Mellitus Tipo 1/complicações , Mycobacterium tuberculosis/isolamento & purificação , Tuberculose Pulmonar/complicações , Tuberculose Pulmonar/epidemiologia , Adolescente , Criança , Pré-Escolar , Estudos Transversais , Diabetes Mellitus Tipo 1/epidemiologia , Feminino , Humanos , Lactente , Masculino , Prevalência , Modelos de Riscos Proporcionais , Fatores de Risco , África do Sul/epidemiologia , Teste Tuberculínico , Adulto JovemRESUMO
OBJECTIVE: To investigate the extent to which relapse and other previously treated tuberculosis (TB) contribute to the notified TB burden in South Africa.DESIGN: We conducted an ecological analysis at the level of the 52 South African health districts using national electronic TB register data. We included all bacteriologically confirmed TB cases treated for presumed drug-susceptible TB in 2011. Treatment history information was based on recorded patient categories (new vs. retreatment).RESULTS: Relapse and other previously treated TB cases constituted between 7.6% and 40% (median 17%, interquartile range 12-22) of all bacteriologically confirmed TB cases in the 52 South African districts. Multivariable analysis suggested that districts with higher proportions of previously treated TB cases had higher TB case notification rates (P < 0.001), lower estimates of antenatal human immunodeficiency virus (HIV) prevalence in the district population (P < 0.001) as well as lower HIV co-infection rates (P < 0.001) among new TB cases.CONCLUSION: Relapse and other previously treated TB cases contributed substantially to the notified TB burden in several South African health districts, particularly those with high case notification rates and lower antenatal HIV prevalence. Additional efforts to prevent TB among previously treated people, such as strengthening treatment monitoring and/or secondary preventive therapy, should be considered.
Assuntos
Efeitos Psicossociais da Doença , Notificação de Doenças/estatística & dados numéricos , Infecções por HIV/epidemiologia , Tuberculose/epidemiologia , Adolescente , Adulto , Antituberculosos/administração & dosagem , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Prevalência , Recidiva , Retratamento/estatística & dados numéricos , África do Sul/epidemiologia , Tuberculose/tratamento farmacológico , Adulto JovemRESUMO
OBJECTIVE: To investigate whether time to detection (TTD) of Mycobacterium tuberculosis in BACTEC Mycobacteria Growth Indicator Tube (MGIT) 960 and BACTEC 460 TB systems can be used as an alternative to colony-forming unit (cfu) counting. DESIGN: A single sputum sample recovered from each of 22 patients with tuberculosis (TB) was cultured on Middlebrook 7H11 agar and in BACTEC MGIT 960 and BACTEC 460 to investigate the relationship between cfu/ml and TTD. The relationship between TTD and treatment response was investigated by culturing a single sputum sample from each of 125 patients with TB in the BACTEC 460 system and comparing TTD values with their treatment response. RESULTS: An inverse correlation between TTD and bacterial number, as assessed by inoculum size and cfu/ml, was observed. For the 125 patients followed up during treatment, TTD values at diagnosis correlated with smear conversion rates at 2 months and treatment outcomes. Drug resistance of the infecting strain was associated with decreased killing, as indicated by the delayed increase in TTD during the first few days of treatment. CONCLUSION: The TTD of M. tuberculosis in BACTEC MGIT 960 and BACTEC 460 TB systems is a viable alternative to colony counting. TTD in liquid culture will facilitate mycobacterial quantification, especially in the evaluation of early bactericidal activity.
Assuntos
Técnicas Bacteriológicas , Contagem de Colônia Microbiana , Mycobacterium tuberculosis/isolamento & purificação , Escarro/microbiologia , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/microbiologia , Humanos , Fatores de Tempo , Tuberculose Pulmonar/tratamento farmacológicoRESUMO
SETTING: Tygerberg district, Western Cape Province, South Africa. OBJECTIVE: To measure the agreement of two interferon-gamma release assays (IGRAs) and the tuberculin skin test (TST) for the detection of Mycobacterium tuberculosis infection in human immunodeficiency virus (HIV) infected adults and children in a setting highly endemic for tuberculosis (TB). DESIGN: Cross-sectional study. RESULTS: In HIV-infected adults (n=20) and children (n=23), tests yielded discordant results, with 61% of individuals testing positive with T-SPOT.TB, 41% with TST and 28% with QuantiFERON TB Gold (QTF). In children, there was poor agreement between the TST and T-SPOT.TB (kappa [kappa]=-0.02), but moderate agreement between the TST and QTF (kappa=0.44). In adults, there was moderate agreement between the TST and T-SPOT.TB (kappa=0.43), and the TST and QTF (kappa = 0.46). In children and adults, there was fair agreement between the T-SPOT.TB and QTF (kappa=0.33). Twenty per cent of adults had >or=1 indeterminate IGRA results. CONCLUSIONS: There is poor to moderate agreement between the TST and IGRAs in HIV-infected adults and children. T-SPOT.TB may have improved sensitivity for detection of M. tuberculosis infection in HIV-infected individuals compared to the QTF and the TST. In HIV-infected individuals, IGRA test properties are affected by test cut-off point and nil control responses.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Testes Imunológicos , Interferon gama/sangue , Mycobacterium tuberculosis/isolamento & purificação , Tuberculose/diagnóstico , Antígenos de Bactérias , Proteínas de Bactérias , Estudos Transversais , Infecções por HIV/complicações , Humanos , Sensibilidade e Especificidade , África do Sul/epidemiologia , Teste Tuberculínico , Tuberculose/complicações , Tuberculose/epidemiologiaRESUMO
A study in 11 primary health care facilities in and around Cape Town determined the proportion of bacteriologically confirmed tuberculosis (TB) cases who did not start treatment (initial default) and identified reasons for it. Databases from centralised laboratories were compared with electronic TB treatment registers. Fourteen per cent (373/2758) of TB suspects were TB cases. Of the 58 (16%) initial defaulters, 14 (24%) died, while 26 (45%) could not be interviewed for address-related reasons. The 18 subjects who were interviewed indicated reasons for initial default that were (56%) or were not (44%) directly linked to services. High initial default rates require improvement in the quality of health services.
Assuntos
Antituberculosos/uso terapêutico , Atenção à Saúde , Cooperação do Paciente , Tuberculose Pulmonar/tratamento farmacológico , Adolescente , Adulto , Criança , Humanos , Ambulatório Hospitalar , Pacientes Ambulatoriais , Estudos Retrospectivos , África do Sul , Escarro/microbiologia , Recusa do Paciente ao Tratamento , Tuberculose Pulmonar/diagnósticoRESUMO
SETTING: Thirteen primary health care (PHC) facilities in the Stellenbosch District, South Africa. OBJECTIVE: To assess the use of a sputum register to evaluate the tuberculosis (TB) diagnostic process and the initiation of TB treatment in selected PHC facilities in a country with a centralised laboratory system. DESIGN: This prospective study was conducted between April 2004 and March 2005. The names of all individuals submitting sputum samples for TB testing were noted in a newly introduced sputum register. We classified all TB suspects with two positive smears as TB cases and consulted TB treatment registers until 3 months after sputum submission to determine how many had started treatment. RESULTS: A total of 4062 persons aged > or =15 years submitted sputum samples, of whom 2484 were TB suspects. There were 2037 suspects with at least two results, 367 (18%) had at least two positive smears and 64 (17%) of these did not start treatment (initial defaulters). Over the entire diagnostic process, up to 5% of TB cases were missed, and up to 26% did not start treatment and were not reported. CONCLUSION: By correcting diagnostic weaknesses identified in the sputum register, PHC facilities will be able to detect, treat and cure a higher percentage of TB patients.
Assuntos
Tuberculose/diagnóstico , Tuberculose/tratamento farmacológico , Adolescente , Adulto , Feminino , Instalações de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Cooperação do Paciente , Estudos Prospectivos , Sistema de Registros , África do Sul , Escarro/microbiologiaRESUMO
SETTING: Cape Town, South Africa. OBJECTIVE: To model the diagnosis of rifampicin-resistant tuberculosis (RR-TB) and laboratory costs of smear/culture and Xpert-based algorithms and the effect of varying adherence and human immunodeficiency virus (HIV) testing in the Xpert-based algorithm. METHODS: We used a validated operational model (100 000 population) and published laboratory cost data. We estimated the number and cost of RR-TB cases identified using the smear/culture- and Xpert-based algorithms. We modelled varying adherence and different levels of known HIV status against the Xpert-based algorithm. RESULTS: The number of RR-TB cases identified increased from 603 with smear/culture to 1178 with the Xpert-based algorithm (100% adherence; 60% knew their HIV status). The overall laboratory cost increased from US$1 073 858 to US$2 430 050 and the cost per RR-TB case identified increased from US$1781 to US$2063 in the respective algorithms. When adherence to the Xpert-based algorithm was increased from 50% to 100% (60% knew their HIV status), the number of RR-TB cases identified increased from 721 to 1178. CONCLUSION: The Xpert-based algorithm is efficient in identifying RR-TB, as the increase in costs is offset by the increase in the number of cases identified. Adherence to the Xpert-based algorithm is important to ensure that all presumptive TB cases receive the benefit of simultaneous TB and RR-TB testing.
Assuntos
Custos e Análise de Custo , Técnicas e Procedimentos Diagnósticos/economia , Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico , Tuberculose Resistente a Múltiplos Medicamentos/economia , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/economia , Algoritmos , Antibióticos Antituberculose/uso terapêutico , Infecções por HIV/diagnóstico , Infecções por HIV/tratamento farmacológico , Humanos , Modelos Econômicos , Rifampina/uso terapêutico , África do Sul/epidemiologia , Escarro/microbiologia , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Tuberculose Pulmonar/tratamento farmacológicoRESUMO
BACKGROUND: A community-based prevalence survey performed in two suburbs in Cape Town, South Africa (SA), in 2005, using the international Burden of Obstructive Lung Disease (BOLD) method, confirmed a prevalence of chronic airflow obstruction (CAO) in 23.1% of adults aged >40 years. OBJECTIVES: To study the clinical course and prognosis over 5 years of patients with CAO identified in the 2005 survey. METHODS: Patients with CAO in 2005 were invited to participate. Standard BOLD and modified questionnaires were completed. Spirometry was performed using spirometers of the same make as in 2005. RESULTS: Of 196 eligible participants from BOLD 2005, 45 (23.0%) had died, 8 from respiratory causes, 10 from cardiovascular causes and 6 from other known causes, while in 21 cases the cause of death was not known. On multivariate analysis, only age and Global initiative for Obstructive Lung Disease (GOLD) stage 4 disease at baseline were significantly associated with death. Of the 151 survivors, 11 (5.6% of the original cohort) were unavailable and 33 (16.8%) declined or had medical exclusions. One hundred and seven survivors were enrolled in the follow-up study (54.6%, median age 63.1 years, 45.8% males). Post-bronchodilator spirometry performed in 106 participants failed to confirm CAO, defined as a forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio of <0.7, in 16 participants (15.1%), but CAO was present in 90. The median decline in FEV1 was 28.9 mL/year (interquartile range -54.8 - 0.0) and was similar between GOLD stages. The median total decline in FVC was 75 mL, and was significantly greater in GOLD stage 1 (-350 mL) than in stages 2 or 3 (-80 mL and +140 mL, respectively; p<0.01). Fifty-eight participants with CAO in 2005 (64.4%) remained in the same GOLD stage, while 21 (23.3%) deteriorated and 11 (12.2%) improved by ≥1 stage. Only one-third were receiving any treatment for chronic obstructive pulmonary disease (COPD). CONCLUSIONS: The prevalence, morbidity and mortality of CAO and COPD in SA are high and the level of appropriate treatment is very low, pointing to underdiagnosis and inadequate provision of and access to effective treatments and preventive strategies for this priority chronic non-communicable disease.
RESUMO
A cohort of pulmonary tuberculosis (TB) patients in a South African admixed population was investigated to determine if the vitamin D receptor gene (VDR) polymorphisms FokI, ApaI, and TaqI are associated with TB susceptibility or time to sputum conversion, and to investigate other clinical and demographic factors affecting the rate of response to treatment. Firstly, a case-control association study of 249 TB cases and 352 healthy controls was carried out to investigate association of VDR polymorphisms with TB susceptibility. Secondly, a cohort of pulmonary tuberculosis patients with conversion times for both sputum smear (n=220) and culture (n=222) were analysed to determine factors contributing to mycobacterial resolution in sputum. Age and gender adjusted Cox regression models were constructed. Our results indicate that the extent of disease at diagnosis was predictive of both smear and culture conversion times in the final models. Smoking status and VDR genotype contributed independently to smear conversion time, with ApaI 'AA' genotype and TaqI 'T'-containing genotypes predictive of a faster response to TB chemotherapy. We did not find an association between VDR genotype and TB in the case-control study. We conclude that the time taken for an individual to convert to sputum negativity while on antituberculosis therapy can be independently predicted by the VDR genotype.
Assuntos
Predisposição Genética para Doença , Polimorfismo de Nucleotídeo Único , Receptores de Calcitriol/genética , Escarro/microbiologia , Tuberculose Pulmonar/genética , Adolescente , Adulto , Idoso , Estudos de Casos e Controles , Feminino , Haplótipos , Humanos , Masculino , Pessoa de Meia-Idade , Análise de Regressão , África do SulRESUMO
SETTING: Cape Town, South Africa. OBJECTIVE: To model the effects of increased case finding and triage strategies on laboratory costs per tuberculosis (TB) case diagnosed. METHODS: We used a validated operational model and published laboratory cost data. We modelled the effect of varying the proportion with TB among presumptive cases and Xpert cartridge price reductions on cost per TB case and per additional TB case diagnosed in the Xpert-based vs. smear/culture-based algorithms. RESULTS: In our current scenario (18.3% with TB among presumptive cases), the proportion of cases diagnosed increased by 8.7% (16.7% vs. 15.0%), and the cost per case diagnosed increased by 142% (US$121 vs. US$50). The cost per additional case diagnosed was US$986. This would increase to US$1619 if the proportion with TB among presumptive cases was 10.6%. At 25.9-30.8% of TB prevalence among presumptive cases and a 50% reduction in Xpert cartridge price, the cost per TB case diagnosed would range from US$50 to US$59 (comparable to the US$48.77 found in routine practice with smear/culture). CONCLUSION: The operational model illustrates the effect of increased case finding on laboratory costs per TB case diagnosed. Unless triage strategies are identified, the approach will not be sustainable, even if Xpert cartridge prices are reduced.
Assuntos
Triagem/economia , Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico , Tuberculose Resistente a Múltiplos Medicamentos/economia , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/economia , Algoritmos , Humanos , Programas de Rastreamento/economia , Prevalência , Reprodutibilidade dos Testes , África do Sul , Escarro/microbiologiaRESUMO
SETTING: Cape Town, South Africa. OBJECTIVE: To compare the diagnostic yield for smear/culture and Xpert® MTB/RIF algorithms and to investigate the mechanisms influencing tuberculosis (TB) yield. METHOD: We developed and validated an operational model of the TB diagnostic process, first with the smear/culture algorithm and then with the Xpert algorithm. We modelled scenarios by varying TB prevalence, adherence to diagnostic algorithms and human immunodeficiency virus (HIV) status. This enabled direct comparisons of diagnostic yield in the two algorithms to be made. RESULTS: Routine data showed that diagnostic yield had decreased over the period of the Xpert algorithm roll-out compared to the yield when the smear/culture algorithm was in place. However, modelling yield under identical conditions indicated a 13.3% increase in diagnostic yield from the Xpert algorithm compared to smear/culture. The model demonstrated that the extensive use of culture in the smear/culture algorithm and the decline in TB prevalence are the main factors contributing to not finding an increase in diagnostic yield in the routine data. CONCLUSION: We demonstrate the benefits of an operational model to determine the effect of scale-up of a new diagnostic algorithm, and recommend that policy makers use operational modelling to make appropriate decisions before new diagnostic algorithms are scaled up.
Assuntos
Algoritmos , Testes Diagnósticos de Rotina/métodos , Modelos Teóricos , Tuberculose/diagnóstico , Fidelidade a Diretrizes , Infecções por HIV/epidemiologia , Humanos , Reação em Cadeia da Polimerase , Prevalência , África do Sul/epidemiologia , Escarro/microbiologia , Tuberculose/epidemiologiaRESUMO
Drivers of and barriers to testing are not well understood for those who have never been tested previously and now self-initiate at a community-based human immuno-deficiency virus (HIV) testing service (CB-HTS). This descriptive study enrolled 229 first-time testers. Participants completed an electronic questionnaire. The majority reported fear and (non) accessibility of HTS as barriers to testing (40% and 24%, respectively). Wanting 'to know my status' and the immediate opportunity to test were reported as drivers of testing (41% and 35%, respectively). Addressing fear of testing and providing an easily accessible opportunity to test may go some way to encouraging those previously untested individuals to test.
Les facteurs qui amènent à réaliser un test et ceux qui les entravent ne sont pas bien compris pour ceux qui n'ont jamais été testés auparavant et en prennent l'initiative dans un service de test pour le virus de l'immunodéficience humaine (VIH) basé en communauté (CB-HTS). Cette étude descriptive a enrôlé 229 patients testés pour la première fois. Les participants ont rempli un questionnaire électronique. La majorité a déclaré que la crainte et la (non) accessibilité du HTS étaient des entraves au test (40% et 24%, respectivement). Vouloir « connaître son statut ¼ et l'opportunité de faire le test immédiatement ont été les moteurs de la réalisation du test (41% et 35%, respectivement). Répondre aux craintes individuelles de se faire tester et offrir une opportunité facilement accessible de le réaliser contribueraient à amener au test ceux qui ne l'ont jamais fait.
No se conocen plenamente los impulsores y los obstáculos a la práctica de las pruebas diagnósticas de la infección por el virus de la inmunodeficiencia humana (VIH), en las personas que nunca han recibido la prueba y que ahora, por iniciativa propia, acuden a los servicios comunitarios que la ofrecen. En el presente estudio descriptivo se incorporaron 229 personas que recibían la prueba diagnóstica por primera vez. Los participantes completaron un cuestionario en formato electrónico. La mayoría refirió como obstáculos a la práctica de la prueba el temor (40%) y la (falta de) accesibilidad de los servicios que la ofrecen (24%). Los factores referidos como impulsores de la búsqueda de la prueba fueron el hecho de 'querer conocer su estado' (41%) y la oportunidad inmediata de hacerla (35%). Abordar el temor de las personas y ofrecer una oportunidad fácilmente accesible de realizar la prueba diagnóstica del VIH puede contribuir a que las personas que nunca han realizado la prueba, la acepten.
RESUMO
Objective: To compare the availability, affordability and acceptability of two non-governmental organisation (NGO) led human immunodeficiency virus (HIV) testing service (HTS) modalities (mobile and stand-alone) with HTS at a public primary health care facility. Methods: Adult participants who self-referred for HIV testing were enrolled as they exited the HTS modalities. Data collection using an electronic questionnaire took place between November 2014 and February 2015. Logistic regression analysis was used to assess differences in the participants' demographic characteristics and the availability, affordability and acceptability of HTS between modalities. Results: There were 130 participants included in the study. Irrespective of modality, most participants walked to the service provider, had a travel time of <30 min and reported no costs. Participants were less likely to report waiting times of ⩾30 min compared to <15 min at the mobile modality compared to the public facility (aOR < 0.001, 95%CI < 0.001-0.03). Conclusion: Irrespective of modality, HIV testing services were available and affordable in our study. Waiting times were significantly higher at the public facility compared to the NGO modalities. As South Africa moves toward achieving the first UNAIDS target, it is essential not only to make HTS available and affordable, but also to ensure that these services are acceptable, especially to those who have never been tested before.
Objectif : Comparer la disponibilité, l'accessibilité et l'acceptabilité de deux modalités de services de test du virus de l'immunodéficience humaine (VIH) (HTS) : modalité mobile réalisée par des organisations non gouvernementales (ONG) et modalité autonome réalisée par une structure de soins de santé primaires.Méthodes : Les participants adultes qui se sont présentés pour un test VIH ont été enrôlés lors de leur sortie des modalités de HTS. Le recueil de données, basé sur un questionnaire électronique, a eu lieu entre novembre 2014 et février 2015. Une analyse de régression logistique a été utilisée afin d'évaluer les différences des caractéristiques démographiques des participants et de la disponibilité, de l'accessibilité et de l'acceptabilité du HTS selon les modalités.Résultats : Des 130 participants qui ont été inclus dans l'étude, quelle que soit la modalité, la majorité s'est rendue à pied chez le prestataire de soins, marchant pendant <30 min, et n'a subi aucun coût. Les participants des structures mobiles ont été moins susceptibles que ceux de la structure publique de rapporter un temps de trajet ⩾ 30 min comparés à <15 min (ORa < 0,001 ; IC95% < 0,0010,03).Conclusion : Les services de test VIH, quelle que soit la modalité, ont été disponibles et abordables dans notre étude. Les durées d'attente ont été significativement plus élevées dans la structure publique comparée aux modalités des ONG. Comme l'Afrique du Sud évolue vers l'atteinte de la première cible de l'ONUSIDA, il est essential non seulement de rendre le HST disponible et abordable, mais également de s'assurer que ces services sont acceptables, surtout à ceux qui n'ont jamais eu de test auparavant.
Objetivo: Comparar la disponibilidad, la asequibilidad y la aceptabilidad de dos modalidades de servicios de pruebas diagnósticas del virus de inmunodeficiencia humana (VIH) (HTS móvil y fijo independiente) propuestas por organizaciones no gubernamentales (ONG) y los servicios diagnósticos propuestos en un establecimiento público de atención primaria de salud.Métodos: Los adultos que acudían de manera espontánea en busca de pruebas diagnósticas se incluyeron en el estudio a la salida de los HTS. Se recogieron datos por conducto de un cuestionario electrónico de noviembre 2014 hasta febrero 2015. Mediante análisis de regresión logística se evaluaron las diferencias en las características demográficas de los participantes y la disponibilidad, la asequibilidad y la aceptabilidad de los HTS según las diferentes modalidades.Resultados: Participaron en el estudio 130 personas. Con independencia de la modalidad, la mayoría de los participantes caminó hasta el punto de prestación de servicios, su tiempo de desplazamiento fue <30 min y refirió no haber incurrido en ningún gasto. Fue menos probable que los usuarios de los servicios móviles refiriesen un tiempo de espera ⩾ 30 min en lugar de <15 min, al compararlos con los usuarios del establecimiento público (P < 0,001; IC95% < 0,0010,03).Conclusión: El presente estudio reveló que los servicios de pruebas diagnósticas del VIH, sea cual fuere su modalidad, estaban disponibles y eran asequibles. Los tiempos de espera fueron significativamente más prolongados en el establecimiento público, en comparación con la espera en las modalidades de las ONG. A medida que Suráfrica progresa hacia el cumplimiento de la primera meta del Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA, es primordial, no solo que los HTS estén disponibles y sean asequibles, sino que se garantice su aceptabilidad, sobre todo por parte las personas que nunca han recibido la prueba.
RESUMO
BACKGROUND: High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough ≥2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of screening while achieving a specificity of ≥85%. METHODS: We used 2010 Zambia South Africa Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) survey data: a South African (SA) training dataset, a SA testing dataset for internal validation and a Zambian dataset for external validation. Regression analyses investigated relationships between symptoms or combinations of symptoms and active disease. Sensitivity and specificity were calculated for candidate rules. RESULTS: Among all participants, the sensitivity of using only cough ≥2 weeks as a screening rule was less than 25% in both SA and Zambia. The addition of any three of six TB symptoms (cough <2 weeks, night sweats, weight loss, fever, chest pain, shortness of breath), or 2 or more of cough <2 weeks, night sweats, and weight loss, increased the sensitivity to ~38%, while reducing specificity from ~95% to ~85% in SA and ~97% to ~92% in Zambia. Among HIV-negative adults, findings were similar in SA, whereas in Zambia the increase in sensitivity was relatively small (15% to 22%). CONCLUSION: High TB burden countries should investigate cost-effective strategies for systematic screening: one such strategy could be to use our rule in addition to cough ≥2 weeks.
Assuntos
Doenças Transmissíveis/epidemiologia , Tosse/epidemiologia , Programas de Rastreamento , Tuberculose/epidemiologia , População Negra , Doenças Transmissíveis/sangue , Doenças Transmissíveis/microbiologia , Tosse/sangue , Tosse/microbiologia , Dispneia/sangue , Dispneia/microbiologia , Feminino , Febre/sangue , Febre/epidemiologia , Febre/microbiologia , Infecções por HIV/sangue , Infecções por HIV/epidemiologia , Humanos , Masculino , Mycobacterium tuberculosis/patogenicidade , Escarro/microbiologia , Suor/microbiologia , Tuberculose/sangue , Tuberculose/microbiologia , ZâmbiaRESUMO
This report documents the bacteriologic yield in children who received treatment for intrathoracic tuberculosis in an area where it is highly endemic. A total of 307 children were included in the study, and bacteriologic confirmation was achieved in 122 (62.2%) of 196 children from whom specimens were collected. The lowest bacteriologic yield was recorded for the 69 children with uncomplicated lymph node disease (24 [34.8%] had bacteriologic confirmation). The high overall bacteriologic yield indicates the need to reassess the value of bacteriology-based approaches to diagnosis of intrathoracic tuberculosis in children, particularly in areas of endemicity where they frequently present with advanced disease.